Palliative treatment of germ cell cancer.
Publisher DOI
PubMed ID
30415106
Abstract
Most patients with metastatic germ-cell cancer (GCC) can be cured by cisplatin-based combination chemotherapy. Yet, about 10-15% of metastatic GCC patients will eventually die of their disease. This narrative review focuses on treatment options when cure is no longer realistic.
Date Issued
2018-12
Publication Type
Article
Subject(s)
Subjects
Drug therapy Germ cell cancer Germ cell tumor Palliative treatment Platinum-refractory
Language(s)
en
Author(s)
Oing, Christoph | |
Giannatempo, Patrizia | |
Honecker, Friedemann | |
Oechsle, Karin | |
Bokemeyer, Carsten |
Additional Credits
Journal
Cancer treatment reviews
Publisher
Elsevier
ISSN
1532-1967
Access(Rights)
open.access